
Sign up to save your podcasts
Or
Mark Cuban invests in dozens of companies, but he’s never put his own name on one before. That changed with Mark Cuban Cost Plus Drug Company. In this conversation, he tells LinkedIn’s Editor-in-Chief, Dan Roth, exactly why he wants to make commonly prescribed prescription drugs available as cheaply as he can, and what industries he thinks up-and-coming entrepreneurs should set their sights on.
Follow Mark Cuban on LinkedIn
Follow Daniel Roth on LinkedIn
Join our This is Working community by subscribing to Dan’s newsletter and posting your thoughts using the hashtag #ThisIsWorking.
4.7
5757 ratings
Mark Cuban invests in dozens of companies, but he’s never put his own name on one before. That changed with Mark Cuban Cost Plus Drug Company. In this conversation, he tells LinkedIn’s Editor-in-Chief, Dan Roth, exactly why he wants to make commonly prescribed prescription drugs available as cheaply as he can, and what industries he thinks up-and-coming entrepreneurs should set their sights on.
Follow Mark Cuban on LinkedIn
Follow Daniel Roth on LinkedIn
Join our This is Working community by subscribing to Dan’s newsletter and posting your thoughts using the hashtag #ThisIsWorking.
199 Listeners
671 Listeners
1,036 Listeners
564 Listeners
3,991 Listeners
7,003 Listeners
1,392 Listeners
9,164 Listeners
1,019 Listeners
335 Listeners
560 Listeners
2,178 Listeners
453 Listeners
648 Listeners
614 Listeners
142 Listeners
103 Listeners
34 Listeners
70 Listeners
156 Listeners
45 Listeners
21 Listeners